![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2014/11/lupus-300x200.jpg)
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Abstract Systemic lupus erythematosus (SLE) is prototypical autoimmune disease driven by pathological T cell–B cell interactions1,2. Expansion of T follicular helper (TFH) and T peripheral